Acute Ischemic Stroke clinical trials
36 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis
- SUMMIT RISE Study of Acute Ischemic Stroke Patients
- Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
- A Study of TAK-755 in Adults With Acute Ischemic Stroke
- Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy
- Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy
- Pulse Endovascular ReperFUSION for Acute Ischemic Stroke
- SEACOAST 1- SEdAtion With COllAteral Support in Endovascular Therapy for Acute Ischemic Stroke
- Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke
- Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well
- Optimizing Reperfusion to Improve Outcomes and Neurologic Function
- Safety and Efficacy of J147 in Acute Ischemic Stroke
- A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT
- Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
- The Pivotal Study of RapidPulseTM Aspiration System
- Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
- Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
- EnDOvascular Therapy for Late WiNdow IschEmic Stroke Patients Selected bY AutoMatic Plain ComputErized Tomography
- Prospective Randomized Observer Blinded Single Center Study Comparing 90-day Functional Outcome in Patients Who Received Intravenous Propofol Infusion Versus Inhalational Sevoflurane for General Anesthesia During Mechanical Thrombectomy in Patients Who Suffered From Acute Ischemic Stroke
- Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?
- Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
- WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
- REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)
- Brain, Blood And Clot or Tissue Registry And Collaboration
- Balloon Guide Versus Conventional Guide Catheter in Stroke Thrombectomy
- Ischemic Conditioning During Air tRansport Save penUmbral Tissue
- Efficacy and Safety of Tenecteplase Among acutE Ischemic Stroke Patients With Recent Ingestion of Direct Oral Anticoagulant
- Virtually Assisted Home Rehabilitation After Stroke for Underserved Texas Communities
- Quelling of Excitotoxicity in Acute Stroke With Ketamine
- Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose
- Evaluation of a Point-of-care Lateral Flow Assay in Glial Fibrillary Acidic Protein (GFAP) and D-dimer in Diagnosis of Large Vessel Occlusion Acute Ischemic Stroke in a Pediatric Hospital
- Reduce Inefficiencies in Management of Spasticity
- Transcranial Doppler Evaluation After Endovascular Thrombectomy for Acute Ischemic Stroke (PRECISE-TCD)
- Endovascular Therapy for Large Core Patients With Uncertain Response to Thrombectomy
- Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Acute Ischemic Stroke” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.